B. PACKAGE LEAFLET 1

Similar documents
ANNEX II A. MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE

Irbenida H 150mg/12,5mg film-coated tablets

Package leaflet: Information for the patient CoAprovel 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

Package leaflet: Information for the user

PATIENT INFORMATION LEAFLET. PACKAGE LEAFLET: INFORMATION FOR THE USER Artin 75 mg tablets Artin 150 mg tablets Artin 300 mg tablets.

Package leaflet: Information for the patient Co-Irbea 150 mg/12.5 mg tablets

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Avsartan 75mg, 150mg, 300mg Tablets Irbesartan Consumer Medicine Information

irbesartan/hydrochlorothiazide

ANNEX III LABELLING AND PACKAGE LEAFLET ANNEX

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Patient Information MICARDIS HCT (my-car-dis HCT) (telmisartan and hydrochlorothiazide) Tablets

PATIENT INFORMATION LEAFLET DYNARB RANGE

CONSUMER MEDICINE INFORMATION

Patient Information Losartan Potassium and Hydrochlorothiazide Tablets, USP 50 mg/12.5 mg, 100 mg/12.5 mg and 100 mg/25 mg Rx only

ANNEX II THE MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR IMPORT AND BATCH RELEASE AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE

Package leaflet: Information for the user

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Sibelium 5 mg Tablets flunarizine

What is in this leaflet

Day Valerian Root Extract Hops Extract. Read all of this leaflet carefully because it contains important information for you.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the patient

Package leaflet: Information for the user. Samsca 7.5 mg tablets Samsca 15 mg tablets Samsca 30 mg tablets tolvaptan

Package leaflet: Information for the patient. Rasilez 150 mg film-coated tablets Rasilez 300 mg film-coated tablets Aliskiren

CONSUMER MEDICINE INFORMATION. Arrow Losartan Potassium & Hydrochlorothiazide

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Irbesartan AN capsules Irbesartan

Pravat 40 mg tablets. Pravastatin sodium

Package leaflet: Information for the user

Package leaflet: Information for the user. Edarbi 20 mg tablets Edarbi 40 mg tablets Edarbi 80 mg tablets Azilsartan medoxomil

Patient Information. Telmisartan and Hydrochlorothiazide (TEL-mi-SAR-tan and HYE-droe-KLOR-oh-THYE-a-zide) Tablets. Rx Only

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package leaflet: Information for the user. Inovelon 400 mg film-coated tablets. Rufinamide

PACKAGE LEAFLET: INFORMATION FOR THE USER. CIALIS 10 mg film-coated tablets tadalafil

Perindopril and Indapamide GH 4/1.25 mg Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE

This leaflet answers some common questions about Micardis Plus. It does not contain all available information.

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package leaflet: Information for the patient. Valsartan 320 mg Film-coated Tablets valsartan

Package Leaflet: Information for the User. BENETOR 10 mg, 20 mg, 40 mg Film-Coated Tablets olmesartan medoxomil

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.

Package leaflet: Information for the user NON DROWSY SUDAFED. DECONGESTANT 60 mg FILM-COATED TABLETS Pseudoephedrine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride

Package leaflet: Information for the patient. Briviact 75 mg film-coated tablets. Briviact 25 mg film-coated tablets

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cinfalair 4 mg chewable tablets

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

What AVAPRO HCT does and how it works

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Comtan is available in bottles containing 30, 60, 100 or 500 tablets. Catechol-O-methyl transferase inhibitor, antiparkinsonian medicinal product

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Indopril perindopril. Consumer Medicine Information (CMI) What is in this leaflet. What INDOPRIL is used for

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

B. PACKAGE LEAFLET 1

1. What Solpadol is and what it is used for

Package Leaflet: Information for the User. Glucosamine sulfate 750 mg Film-Coated Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. InductOs 12 mg kit for implant dibotermin alfa

Package leaflet: Information for the user Salofalk 500mg gastro-resistant tablets Mesalazine

PATIENT INFORMATION LEAFLET TEXAMER

B. PACKAGE LEAFLET 1

Package Leaflet: Information for the User. VOTUM 10 mg, 20 mg, 40 mg Film-Coated Tablets olmesartan medoxomil

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Sebivo 600 mg film-coated tablets Telbivudine

1. What Betahistine dihydrochloride tablets is and what it is used for

Package Leaflet: Information for the user. OLMETEC 10 mg, 20 mg, 40 mg Film-Coated Tablets olmesartan medoxomil

PATIENT INFORMATION LEAFLET PEARINDA PLUS

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

Motens 2 mg and 4 mg Tablets lacidipine

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

What ABISART does and how it works

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

B. PACKAGE LEAFLET 18

2 What you need to know before you take Naramig

Chemmart Irbesartan HCTZ Tablets Contains the active ingredients, irbesartan and hydrochlorothiazide

Irbesartan HCT GH. Consumer Medicine Information

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

Transcription:

B. PACKAGE LEAFLET 1

Karvezide 150/12.5 mg tablets Irbesartan/hydrochlorothiazide PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START TO TAKE YOUR TABLETS Your doctor has prescribed this medicine for you. Do not give it to anyone else. This leaflet contains a summary of the information on your medicine. If you have questions or want more information, please ask your doctor or pharmacist. Keep this leaflet while you are taking Karvezide tablets, as you may want to read it again. COMPOSITION The active substances in Karvezide tablets are irbesartan and hydrochlorothiazide. Each tablet of Karvezide 150/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide. The tablets contain the following excipients: microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, red and yellow ferric oxides (E172). Karvezide tablets are supplied in blister packs of 28, 56 or 98. TYPE OF MEDICINE Karvezide is a combination of two active substances, irbesartan and hydrochlorothiazide. Irbesartan belongs to a group of medicines known as angiotensin-ii receptor antagonists. Angiotensin-II is a substance produced in the body that binds to receptors in blood vessels causing them to tighten. This results in an increase in blood pressure. Irbesartan prevents the binding of angiotensin-ii to these receptors, causing the blood vessels to relax and the blood pressure to lower. Hydrochlorothiazide is one of a group of medicines (called thiazide diuretics) that causes increased urine output and so causes a lowering of blood pressure. The two active ingredients in Karvezide work together to lower blood pressure further than if either was given alone. MARKETING AUTHORISATION HOLDER PHARMA EEIG Swakeleys House, Milton Road Ickenham UB10 8 PU - United Kingdom MANUFACTURER SANOFI WINTHROP INDUSTRIE 1 rue de la Vierge F-33440 Ambarès - France WHEN SHOULD Karvezide BE USED? Karvezide is used in the treatment of high blood pressure (hypertension), when a combination of two active substances is deemed appropriate. This is usually the case when treatment with one active substance alone did not provide adequate control of your blood pressure. 2

Your doctor measured your blood pressure and found it to be above the normal range for your age. High blood pressure, if not treated, can damage blood vessels in several organs such as the heart, the kidneys, the brain and the eyes. In some instances, this may lead to heart attacks, heart or kidney failure, strokes, or blindness. There are usually no symptoms of high blood pressure before damage occurs. Thus, measurement of the blood pressure is necessary to verify if it is in the normal range or not. High blood pressure can be treated and controlled with medicines such as Karvezide. Your doctor may also have recommended that you adjust your lifestyle to help to lower your high blood pressure (losing weight, avoiding smoking, reducing alcohol consumption and restricting the amount of salt in the diet). Your doctor may also have encouraged the practice of regular, mild (not strenuous) exercise such as walking and swimming. IMPORTANT INFORMATION BEFORE TAKING Karvezide: When should Karvezide not be used? Do not take Karvezide if: you are or think you may be pregnant, you are planning to become pregnant, you are breast-feeding, you have severe liver or kidney problems (ask your doctor if you have any doubt), you have difficulty in producing urine, you have a condition which is associated with persistently high calcium or low potassium levels in your blood, or you are allergic to any of the ingredients (see Composition ) or to sulfonamide-derived medicines. If any of the above apply to you, inform your doctor or pharmacist first and ask for their advice. Other appropriate precautions before use There are certain conditions that you may have, or have had, which require special care before or while taking Karvezide. Therefore, before taking this medicine, you should have told your doctor if you suffer from: excessive vomiting or diarrhoea, kidney problems, including kidney transplantation, heart problems, liver problems, diabetes or lupus erythematosus (also known as lupus or SLE). You should also tell your doctor if you are on a low-salt diet. 3

Signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat may indicate an excessive effect of hydrochlorothiazide (contained in Karvezide) for which you should consult your doctor. If you are to undergo any surgery or receive anaesthetics, you should make sure the doctor knows that you are taking Karvezide tablets. Hydrochlorothiazide contained in this medication could produce a positive result in an anti-doping test. CAN YOU TAKE Karvezide WITH OTHER MEDICINES? You should have informed your doctor of any medicines you are taking. These include medicines obtained without prescription. Diuretic agents such as the hydrochlorothiazide contained in Karvezide may interact with other medicines. Preparations containing lithium should not be taken with Karvezide without close supervision by your doctor. Special precautionary measures (e.g. blood tests) may be appropriate if you take potassium supplements, potassium-containing salt substitutes or potassium sparing medicines, other diuretics (water tablets), some laxatives, medicines for the treatment of gout, therapeutic vitamin D supplements, medicines to control heart rhythm or for diabetes (oral agents or insulins). It is also important for your doctor to know if you are taking other medicines to reduce your blood pressure, steroids, medicines to treat cancer, pain killers or arthritis medicines. CAN Karvezide BE USED DURING PREGNANCY OR BREAST-FEEDING? Karvezide should not be used during pregnancy or if you are breast-feeding (see When should Karvezide not be used ). CAN YOU DRIVE OR OPERATE MACHINERY WHILE TAKING Karvezide? Karvezide is unlikely to affect your ability to drive or use machines. However, occasionally dizziness or weariness may occur during treatment of high blood pressure. If you experience these, you should consult your doctor before attempting such activities. HOW SHOULD YOU TAKE Karvezide? The tablets should be taken regularly as directed by your doctor. Karvezide will usually be prescribed by your doctor when your previous treatment for high blood pressure did not provide appropriate blood pressure reduction. Your doctor will instruct you how to switch from the previous treatment to Karvezide. The usual dose of Karvezide is one tablet a day. The maximal blood pressure lowering effect should be reached 6-8 weeks after beginning treatment. Should your blood pressure not be appropriately reduced with Karvezide, your doctor may prescribe an additional medicine. Karvezide can be taken with or without food. The tablets should be swallowed with a drink of water. You should try to take your daily dose at about the same time each day. It is important that you continue to take Karvezide until your doctor tells you otherwise. Karvezide should not be given to children (< 18 years). OVERDOSE If you accidentally take too many tablets, or a child swallows some, contact your doctor immediately. 4

MISSING A DOSE If you accidentally miss a daily dose, just take the next dose as normal. Do not take a double dose to make up for the missed dose. ARE THERE SIDE EFFECTS WHEN TAKING Karvezide? All medicines may cause some side effects. Side effects with Karvezide are generally rare and of a temporary nature. They are generally mild and do not normally require treatment to be interrupted. In clinical studies, symptoms or feelings most often reported by patients taking Karvezide or placebo (sugar tablets) included: headache, dizziness, fatigue, nausea/vomiting or abnormal urination. Of these, only fatigue was reported more often by patients taking Karvezide compared to patients taking placebo. As for any combination of two active substances, side effects associated with each individual component cannot be excluded. In clinical studies with irbesartan alone, only minor injuries, most likely related to physical activity (like muscle and joint sprains), and on rare occasions flushing, were reported more often by patients taking irbesartan compared to patients taking placebo (sugar tablets). It was not clear if these were due to the medicine. The symptoms or feelings most often reported by patients taking irbesartan or placebo included: respiratory infections (like colds and flu), aches and pains (like headache and muscle aches), and dizziness. None of these was reported more often by patients taking irbesartan compared to patients taking placebo. Rarely, patients taking similar medicines have developed localised swelling of the face, lips and/or tongue. This might also occur occasionally with irbesartan. If you think you are developing such a reaction or get short of breath stop taking Karvezide and seek immediate medical attention. The other component of Karvezide (hydrochlorothiazide) has been associated rarely with other more serious side effects mainly affecting the blood, the skin or the kidneys. While this was not observed with Karvezide, occurrence of such side effects cannot be excluded. If you notice abnormal symptoms or feelings while taking Karvezide, you should inform your doctor or pharmacist and ask for their advice. HOW SHOULD YOU STORE YOUR Karvezide TABLETS? Keep all medicines out of the reach of children. Do not store above 30 C. Store in the original package. You will see an expiry date on the carton and on the blister. Do not use the tablets after this date. Do not remove the tablets from the blister pack until you are ready to take the medicine. DATE OF LAST REVISION OF THIS LEAFLET OTHER INFORMATION If you would like more information on your disease or treatment, you should ask your doctor or pharmacist. 5

Further information For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. Belgique/België/Belgien BELGIUM SA/NV chée de la Hulpe 185 / Terhulpsestwg 185 B-1170 Bruxelles/Brussel/Brüssel Tel. : +32 2 352 74 60 Danmark Jaegersborgvej 64-66 DK-2800 Lyngby Tel. : +45 45 93 05 06 Deutschland GMBH Sapporobogen 6-8 D-80809 München Tel. : +49 89 121 42-0 Ελλάδα AEBE 11 χλμ Εθνικής Οδού Αθηνών - Λαμίας GR-144 51 Μεταμόρφωση Αττικής Τηλ : +30 1 281 33 90 España BRISTOL-MYERS, S.A. c/ Almansa, 101 E-28040 Madrid Tel. : +34 91 456 53 00 France La Grande Arche Nord F-92044 Paris La Défense Cedex Tel. : +33 1 40 90 66 99 Ireland PHARMACEUTICALS LTD Watery Lane IRL-Swords, Co. Dublin Tel. : +353 1 840 62 44 Italia SpA Via Virgilio Maroso, 50 I-00142 Roma Tel. : +39 06 50 39 61 Luxembourg/Luxemburg BELGIUM SA/NV chée de la Hulpe 185 / Terhulpsestwg 185 B-1170 Bruxelles/Brussel/Brüssel Belgium Tel. : +32 2 352 74 60 Nederland BV Vijzelmolenlaan 9 NL-3447 GX Woerden Tel. : +31 34 857 42 22 Österreich GESMBH Columbusgasse 4 A-1101 Wien Tel. : +43 1 60 14 30 Portugal FARMACÊUTICA PORTUGUESA, LDA Quinta da Fonte P-2780 Porto Salvo Tel. : +351 1 440 70 00 Suomi/Finland OY (FINLAND) AB Valkjärventie 2 FIN-02130 Espoo Puh/Tel. : +358 9 43 57 73 00 Sverige AB Box 15200 S-161 15 Bromma Tel. : +46 8 704 71 00 United Kingdom PHARMACEUTICALS LTD 141-149 Staines Road Hounslow TW3 3JA - UK Tel. : +44 181 754 37 40 6

Karvezide 300/12.5 mg tablets Irbesartan/hydrochlorothiazide PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START TO TAKE YOUR TABLETS Your doctor has prescribed this medicine for you. Do not give it to anyone else. This leaflet contains a summary of the information on your medicine. If you have questions or want more information, please ask your doctor or pharmacist. Keep this leaflet while you are taking Karvezide tablets, as you may want to read it again. COMPOSITION The active substances in Karvezide tablets are irbesartan and hydrochlorothiazide. Each tablet of Karvezide 300/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide. The tablets contain the following excipients: microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, red and yellow ferric oxides (E172). Karvezide tablets are supplied in blister packs of 28, 56 or 98. TYPE OF MEDICINE Karvezide is a combination of two active substances, irbesartan and hydrochlorothiazide. Irbesartan belongs to a group of medicines known as angiotensin-ii receptor antagonists. Angiotensin-II is a substance produced in the body that binds to receptors in blood vessels causing them to tighten. This results in an increase in blood pressure. Irbesartan prevents the binding of angiotensin-ii to these receptors, causing the blood vessels to relax and the blood pressure to lower. Hydrochlorothiazide is one of a group of medicines (called thiazide diuretics) that causes increased urine output and so causes a lowering of blood pressure. The two active ingredients in Karvezide work together to lower blood pressure further than if either was given alone. MARKETING AUTHORISATION HOLDER PHARMA EEIG Swakeleys House, Milton Road Ickenham UB10 8 PU - United Kingdom MANUFACTURER SANOFI WINTHROP INDUSTRIE 1 rue de la Vierge F-33440 Ambarès - France WHEN SHOULD Karvezide BE USED? Karvezide is used in the treatment of high blood pressure (hypertension), when a combination of two active substances is deemed appropriate. This is usually the case when treatment with one active substance alone did not provide adequate control of your blood pressure. 7

Your doctor measured your blood pressure and found it to be above the normal range for your age. High blood pressure, if not treated, can damage blood vessels in several organs such as the heart, the kidneys, the brain and the eyes. In some instances, this may lead to heart attacks, heart or kidney failure, strokes, or blindness. There are usually no symptoms of high blood pressure before damage occurs. Thus, measurement of the blood pressure is necessary to verify if it is in the normal range or not. High blood pressure can be treated and controlled with medicines such as Karvezide. Your doctor may also have recommended that you adjust your lifestyle to help to lower your high blood pressure (losing weight, avoiding smoking, reducing alcohol consumption and restricting the amount of salt in the diet). Your doctor may also have encouraged the practice of regular, mild (not strenuous) exercise such as walking and swimming. IMPORTANT INFORMATION BEFORE TAKING Karvezide: When should Karvezide not be used? Do not take Karvezide if: you are or think you may be pregnant, you are planning to become pregnant, you are breast-feeding, you have severe liver or kidney problems (ask your doctor if you have any doubt), you have difficulty in producing urine, you have a condition which is associated with persistently high calcium or low potassium levels in your blood, or you are allergic to any of the ingredients (see Composition ) or to sulfonamide-derived medicines. If any of the above apply to you, inform your doctor or pharmacist first and ask for their advice. Other appropriate precautions before use There are certain conditions that you may have, or have had, which require special care before or while taking Karvezide. Therefore, before taking this medicine, you should have told your doctor if you suffer from: excessive vomiting or diarrhoea, kidney problems, including kidney transplantation, heart problems, liver problems, diabetes or lupus erythematosus (also known as lupus or SLE). You should also tell your doctor if you are on a low-salt diet. 8

Signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat may indicate an excessive effect of hydrochlorothiazide (contained in Karvezide) for which you should consult your doctor. If you are to undergo any surgery or receive anaesthetics, you should make sure the doctor knows that you are taking Karvezide tablets. Hydrochlorothiazide contained in this medication could produce a positive result in an anti-doping test. CAN YOU TAKE Karvezide WITH OTHER MEDICINES? You should have informed your doctor of any medicines you are taking. These include medicines obtained without prescription. Diuretic agents such as the hydrochlorothiazide contained in Karvezide may interact with other medicines. Preparations containing lithium should not be taken with Karvezide without close supervision by your doctor. Special precautionary measures (e.g. blood tests) may be appropriate if you take potassium supplements, potassium-containing salt substitutes or potassium sparing medicines, other diuretics (water tablets), some laxatives, medicines for the treatment of gout, therapeutic vitamin D supplements, medicines to control heart rhythm or for diabetes (oral agents or insulins). It is also important for your doctor to know if you are taking other medicines to reduce your blood pressure, steroids, medicines to treat cancer, pain killers or arthritis medicines. CAN Karvezide BE USED DURING PREGNANCY OR BREAST-FEEDING? Karvezide should not be used during pregnancy or if you are breast-feeding (see When should Karvezide not be used ). CAN YOU DRIVE OR OPERATE MACHINERY WHILE TAKING Karvezide? Karvezide is unlikely to affect your ability to drive or use machines. However, occasionally dizziness or weariness may occur during treatment of high blood pressure. If you experience these, you should consult your doctor before attempting such activities. HOW SHOULD YOU TAKE Karvezide? The tablets should be taken regularly as directed by your doctor. Karvezide will usually be prescribed by your doctor when your previous treatment for high blood pressure did not provide appropriate blood pressure reduction. Your doctor will instruct you how to switch from the previous treatment to Karvezide. The usual dose of Karvezide is one tablet a day. The maximal blood pressure lowering effect should be reached 6-8 weeks after beginning treatment. Should your blood pressure not be appropriately reduced with Karvezide, your doctor may prescribe an additional medicine. Karvezide can be taken with or without food. The tablets should be swallowed with a drink of water. You should try to take your daily dose at about the same time each day. It is important that you continue to take Karvezide until your doctor tells you otherwise. Karvezide should not be given to children (< 18 years). OVERDOSE If you accidentally take too many tablets, or a child swallows some, contact your doctor immediately. 9

MISSING A DOSE If you accidentally miss a daily dose, just take the next dose as normal. Do not take a double dose to make up for the missed dose. ARE THERE SIDE EFFECTS WHEN TAKING Karvezide? All medicines may cause some side effects. Side effects with Karvezide are generally rare and of a temporary nature. They are generally mild and do not normally require treatment to be interrupted. In clinical studies, symptoms or feelings most often reported by patients taking Karvezide or placebo (sugar tablets) included: headache, dizziness, fatigue, nausea/vomiting or abnormal urination. Of these, only fatigue was reported more often by patients taking Karvezide compared to patients taking placebo. As for any combination of two active substances, side effects associated with each individual component cannot be excluded. In clinical studies with irbesartan alone, only minor injuries, most likely related to physical activity (like muscle and joint sprains), and on rare occasions flushing, were reported more often by patients taking irbesartan compared to patients taking placebo (sugar tablets). It was not clear if these were due to the medicine. The symptoms or feelings most often reported by patients taking irbesartan or placebo included: respiratory infections (like colds and flu), aches and pains (like headache and muscle aches), and dizziness. None of these was reported more often by patients taking irbesartan compared to patients taking placebo. Rarely, patients taking similar medicines have developed localised swelling of the face, lips and/or tongue. This might also occur occasionally with irbesartan. If you think you are developing such a reaction or get short of breath stop taking Karvezide and seek immediate medical attention. The other component of Karvezide (hydrochlorothiazide) has been associated rarely with other more serious side effects mainly affecting the blood, the skin or the kidneys. While this was not observed with Karvezide, occurrence of such side effects cannot be excluded. If you notice abnormal symptoms or feelings while taking Karvezide, you should inform your doctor or pharmacist and ask for their advice. HOW SHOULD YOU STORE YOUR Karvezide TABLETS? Keep all medicines out of the reach of children. Do not store above 30 C. Store in the original package. You will see an expiry date on the carton and on the blister. Do not use the tablets after this date. Do not remove the tablets from the blister pack until you are ready to take the medicine. DATE OF LAST REVISION OF THIS LEAFLET OTHER INFORMATION If you would like more information on your disease or treatment, you should ask your doctor or pharmacist. 10

Further information For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. Belgique/België/Belgien BELGIUM SA/NV chée de la Hulpe 185 / Terhulpsestwg 185 B-1170 Bruxelles/Brussel/Brüssel Tel. : +32 2 352 74 60 Danmark Jaegersborgvej 64-66 DK-2800 Lyngby Tel. : +45 45 93 05 06 Deutschland GMBH Sapporobogen 6-8 D-80809 München Tel. : +49 89 121 42-0 Ελλάδα AEBE 11 χλμ Εθνικής Οδού Αθηνών - Λαμίας GR-144 51 Μεταμόρφωση Αττικής Τηλ : +30 1 281 33 90 España BRISTOL-MYERS, S.A. c/ Almansa, 101 E-28040 Madrid Tel. : +34 91 456 53 00 France La Grande Arche Nord F-92044 Paris La Défense Cedex Tel. : +33 1 40 90 66 99 Ireland PHARMACEUTICALS LTD Watery Lane IRL-Swords, Co. Dublin Tel. : +353 1 840 62 44 Italia SpA Via Virgilio Maroso, 50 I-00142 Roma Tel. : +39 06 50 39 61 Luxembourg/Luxemburg BELGIUM SA/NV chée de la Hulpe 185 / Terhulpsestwg 185 B-1170 Bruxelles/Brussel/Brüssel Belgium Tel. : +32 2 352 74 60 Nederland BV Vijzelmolenlaan 9 NL-3447 GX Woerden Tel. : +31 34 857 42 22 Österreich GESMBH Columbusgasse 4 A-1101 Wien Tel. : +43 1 60 14 30 Portugal FARMACÊUTICA PORTUGUESA, LDA Quinta da Fonte P-2780 Porto Salvo Tel. : +351 1 440 70 00 Suomi/Finland OY (FINLAND) AB Valkjärventie 2 FIN-02130 Espoo Puh/Tel. : +358 9 43 57 73 00 Sverige AB Box 15200 S-161 15 Bromma Tel. : +46 8 704 71 00 United Kingdom PHARMACEUTICALS LTD 141-149 Staines Road Hounslow TW3 3JA - UK Tel. : +44 181 754 37 40 11